ImmunOs Therapeutics
Schlieren
About ImmunOs Therapeutics
ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $101.8M
- Funding stage: Late Stage Venture
- Last round: Series C (Sep 2024)
- Website: immunostherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/immunos-therapeutics-89188 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.